Pacific Biosciences Of California | PACB - Equity Capital And Reserves


Pacific Biosciences Of California reported $2.37M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Danaher USD 52.95B 415M Mar/2026
General Electric Aerospace USD 18.06B 841M Mar/2026
Illumina USD 2.68B 47M Mar/2026
Myriad Genetics USD 337.4M 30.6M Mar/2026
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Standard Biotools USD 561.12M 136.83M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 2.56B 230.55M Dec/2025